Occasionally I have read that some survivor says that getting cancer was the best thing that ever happened to him. I think, “That person is insane.” We all have a story to tell. The story may help explain how we live our lives and why we are who we are. It may not; but I have not yet met a person who has lived with cancer and has not been changed by the experience. This story is about my experience living with cancer and participating in a recent clinical trial.
A French phase I clinical trial, combining Gleevec + interleukin 2 (IL-2) should open in April 2007 at the Institute Gustave Roussy in Villejuif, France. The aim of this study, organized by a team of Professor Laurence Zitvogel’s, is to evaluate the efficacy as well as the toxicity of this medicinal combination in the treatment of various cancers, including GIST, but also to identify the presence and the action of Interferon Killer Dendritic Cells (IKDCs) in humans.